Literature DB >> 8107260

Varicella-zoster virus open reading frame 4 protein is functionally distinct from and does not complement its herpes simplex virus type 1 homolog, ICP27.

H Moriuchi1, M Moriuchi, H A Smith, J I Cohen.   

Abstract

Varicella-zoster virus (VZV) open reading frame 4 (ORF4) encodes a putative immediate-early protein which is homologous to herpes simplex virus type 1 (HSV-1) ICP27 on the basis of gene location and similarity in amino acid sequence. In transient expression assays, however, ORF4 and ICP27 exhibit different properties. ICP27 alone has little activity on target plasmids, but it acts as a transactivator or a transrepressor in the presence of other HSV-1 transactivators. In contrast, ORF4 directly transactivates plasmids containing homologous or heterologous promoters and has no apparent transrepressing activity. To further illuminate the functional similarities and differences between ORF4 and ICP27, Vero cell lines which express ORF4 under the inducible metallothionein promoter were constructed. Cell lines expressing functionally active ORF4 protein upregulated the expression of transfected VZV target plasmids but were unable to efficiently complement HSV-1 ICP27 mutants. These results indicate that, despite structural similarities, VZV ORF4 and HSV-1 ICP27 behave differently in transient expression assays and may play different roles in virus replication.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8107260      PMCID: PMC236664     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Latent herpes simplex virus in human trigeminal ganglia. Detection of an immediate early gene "anti-sense" transcript by in situ hybridization.

Authors:  K D Croen; J M Ostrove; L J Dragovic; J E Smialek; S E Straus
Journal:  N Engl J Med       Date:  1987-12-03       Impact factor: 91.245

2.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

Authors:  P J Southern; P Berg
Journal:  J Mol Appl Genet       Date:  1982

3.  The products of herpes simplex virus type 1 (HSV-1) immediate early genes 1, 2 and 3 can activate HSV-1 gene expression in trans.

Authors:  R D Everett
Journal:  J Gen Virol       Date:  1986-11       Impact factor: 3.891

4.  Varicella-zoster virus complements herpes simplex virus type 1 temperature-sensitive mutants.

Authors:  J M Felser; S E Straus; J M Ostrove
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

5.  The complete DNA sequence of varicella-zoster virus.

Authors:  A J Davison; J E Scott
Journal:  J Gen Virol       Date:  1986-09       Impact factor: 3.891

6.  The herpes simplex virus type 1 alpha protein ICP27 can act as a trans-repressor or a trans-activator in combination with ICP4 and ICP0.

Authors:  R E Sekulovich; K Leary; R M Sandri-Goldin
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

7.  Varicella-zoster virus DNA polymerase and major DNA-binding protein genes have overlapping divergent promoters.

Authors:  J L Meier; S E Straus
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

8.  Cell lines containing varicella-zoster virus open reading frame 62 and expressing the "IE" 175 protein complement ICP4 mutants of herpes simplex virus type 1.

Authors:  J M Felser; P R Kinchington; G Inchauspe; S E Straus; J M Ostrove
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

9.  Directionality and further mapping of varicella zoster virus transcripts.

Authors:  W C Reinhold; S E Straus; J M Ostrove
Journal:  Virus Res       Date:  1988-02       Impact factor: 3.303

10.  Identification of immediate early genes from herpes simplex virus that transactivate the virus thymidine kinase gene.

Authors:  I H Gelman; S Silverstein
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

View more
  35 in total

1.  UL54-null pseudorabies virus is attenuated in mice but productively infects cells in culture.

Authors:  Jennifer A Schwartz; Elizabeth E Brittle; Ashley E Reynolds; Lynn W Enquist; Saul J Silverstein
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

2.  Promoter- and cell-specific transcriptional transactivation by the Kaposi's sarcoma-associated herpesvirus ORF57/Mta protein.

Authors:  Diana Palmeri; Sophia Spadavecchia; Kyla Driscoll Carroll; David M Lukac
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

3.  Negative autoregulation of Epstein-Barr virus (EBV) replicative gene expression by EBV SM protein.

Authors:  Dinesh Verma; Chen Ling; Eric Johannsen; Tirumuru Nagaraja; Sankar Swaminathan
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

4.  Stability of structured Kaposi's sarcoma-associated herpesvirus ORF57 protein is regulated by protein phosphorylation and homodimerization.

Authors:  Vladimir Majerciak; Natalia Pripuzova; Calvin Chan; Nicholas Temkin; Suzanne I Specht; Zhi-Ming Zheng
Journal:  J Virol       Date:  2015-01-07       Impact factor: 5.103

5.  The conserved carboxyl-terminal half of herpes simplex virus type 1 regulatory protein ICP27 is dispensable for viral growth in the presence of compensatory mutations.

Authors:  S M Bunnell; S A Rice
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  Varicella-zoster virus (VZV) open reading frame 10 protein, the homolog of the essential herpes simplex virus protein VP16, is dispensable for VZV replication in vitro.

Authors:  J I Cohen; K Seidel
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

7.  The varicella-zoster virus (VZV) open reading frame 47 (ORF47) protein kinase is dispensable for viral replication and is not required for phosphorylation of ORF63 protein, the VZV homolog of herpes simplex virus ICP22.

Authors:  T C Heineman; J I Cohen
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency.

Authors:  S Debrus; C Sadzot-Delvaux; A F Nikkels; J Piette; B Rentier
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

9.  Cellular transcription factors Sp1 and Sp3 suppress varicella-zoster virus origin-dependent DNA replication.

Authors:  Mohamed I Khalil; John Hay; William T Ruyechan
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

10.  Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor.

Authors:  Zhen Zhang; Anca Selariu; Charles Warden; Grace Huang; Ying Huang; Oluleke Zaccheus; Tong Cheng; Ningshao Xia; Hua Zhu
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.